We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
•Shares of FMC Corporation (FMC - Free Report) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD - Free Report) crop protection business.
•BlackBerry Ltd’s shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
•Shares of Akari Therapeutics, Plc (AKTX - Free Report) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
•TRC Companies, Inc.’s shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
•Shares of FMC Corporation (FMC - Free Report) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD - Free Report) crop protection business.
•BlackBerry Ltd’s shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
•Shares of Akari Therapeutics, Plc (AKTX - Free Report) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
•TRC Companies, Inc.’s shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
•Shares of FMC Corporation (FMC - Free Report) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD - Free Report) crop protection business.
•BlackBerry Ltd’s shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
•Shares of Akari Therapeutics, Plc (AKTX - Free Report) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
•TRC Companies, Inc.’s shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
•Shares of FMC Corporation (FMC - Free Report) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD - Free Report) crop protection business.
•BlackBerry Ltd’s shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
•Shares of Akari Therapeutics, Plc (AKTX - Free Report) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
•TRC Companies, Inc.’s shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
Shares of FMC Corporation (FMC - Free Report) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD - Free Report) crop protection business.
BlackBerry Ltd’s shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
Shares of Akari Therapeutics, Plc (AKTX - Free Report) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
TRC Companies, Inc.’s shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
•Shares of FMC Corporation (FMC - Free Report) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD - Free Report) crop protection business.
•BlackBerry Ltd’s shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
•Shares of Akari Therapeutics, Plc (AKTX - Free Report) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
•TRC Companies, Inc.’s shares gained 46% after private equity firm New Mountain Capital decided to acquire the compan
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Company News for April 03, 2017